Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 5
1951 7
1952 6
1953 6
1954 16
1955 4
1956 8
1957 11
1958 9
1959 7
1960 4
1961 6
1962 10
1963 12
1964 8
1965 13
1966 7
1967 10
1968 5
1969 10
1970 10
1971 7
1972 9
1973 9
1974 11
1975 19
1976 15
1977 12
1978 19
1979 14
1980 16
1981 11
1982 13
1983 19
1984 19
1985 23
1986 22
1987 15
1988 15
1989 19
1990 20
1991 18
1992 19
1993 28
1994 30
1995 30
1996 38
1997 47
1998 51
1999 51
2000 55
2001 46
2002 55
2003 67
2004 70
2005 73
2006 69
2007 69
2008 73
2009 77
2010 68
2011 95
2012 97
2013 88
2014 91
2015 93
2016 98
2017 109
2018 133
2019 141
2020 118
2021 125
2022 134
2023 131
2024 104
2025 105

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,946 results

Results by year

Filters applied: . Clear all
Page 1
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty.
Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Nagatomi Y, et al. Among authors: higuchi t. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9. ESC Heart Fail. 2022. PMID: 35534907 Free PMC article. Clinical Trial.
Molecular imaging along the heart-kidney axis.
Klimek K, Groener D, Chen X, Rowe SP, Speer T, Higuchi T, Werner RA. Klimek K, et al. Among authors: higuchi t. Theranostics. 2024 Oct 21;14(18):7111-7121. doi: 10.7150/thno.102552. eCollection 2024. Theranostics. 2024. PMID: 39629123 Free PMC article. Review.
Theranostics in Hematooncology.
Buck AK, Serfling SE, Kraus S, Samnick S, Dreher N, Higuchi T, Rasche L, Einsele H, Werner RA. Buck AK, et al. Among authors: higuchi t. J Nucl Med. 2023 Jul;64(7):1009-1016. doi: 10.2967/jnumed.122.265199. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290799 Free PMC article.
FAPI-PET in Cardiovascular Disease.
Higuchi T, Serfling SE, Leistner DM, Speer T, Werner RA. Higuchi T, et al. Semin Nucl Med. 2024 Sep;54(5):747-752. doi: 10.1053/j.semnuclmed.2024.02.006. Epub 2024 Mar 21. Semin Nucl Med. 2024. PMID: 38519308 Free article. Review.
Red Bull PET/CT.
Serfling SE, Buck A, Rowe SP, Higuchi T, Werner R. Serfling SE, et al. Among authors: higuchi t. Nuklearmedizin. 2024 Apr;63(2):76-77. doi: 10.1055/a-2195-0138. Epub 2023 Dec 22. Nuklearmedizin. 2024. PMID: 38134943 Free PMC article.
Infant with Seizures.
Higuchi T, Nakao H. Higuchi T, et al. Ann Emerg Med. 2025 Sep;86(3):288-289. doi: 10.1016/j.annemergmed.2025.03.015. Ann Emerg Med. 2025. PMID: 40846430 No abstract available.
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0.
Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP. Werner RA, et al. Among authors: higuchi t. Eur Urol. 2023 Nov;84(5):491-502. doi: 10.1016/j.eururo.2023.06.008. Epub 2023 Jul 4. Eur Urol. 2023. PMID: 37414701 Free PMC article.
Preclinical Imaging of Cardiovascular Disesase.
Nekolla SG, Rischpler C, Higuchi T. Nekolla SG, et al. Among authors: higuchi t. Semin Nucl Med. 2023 Sep;53(5):586-598. doi: 10.1053/j.semnuclmed.2023.04.004. Epub 2023 Jun 1. Semin Nucl Med. 2023. PMID: 37268498 Review.
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.
Yamashita T, Saji S, Takano T, Naito Y, Tsuneizumi M, Yoshimura A, Takahashi M, Tsurutani J, Iwatani T, Kitada M, Tada H, Mori N, Higuchi T, Iwasa T, Araki K, Koizumi K, Hasegawa H, Uchida Y, Morita S, Masuda N. Yamashita T, et al. Among authors: higuchi t. J Clin Oncol. 2025 Apr 10;43(11):1302-1313. doi: 10.1200/JCO-24-01888. Epub 2025 Jan 9. J Clin Oncol. 2025. PMID: 39787453 Free PMC article. Clinical Trial.
2,946 results